Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$9.57
+2.90%
Mkt Cap $1.68B
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
Implied Upside
+88.1%
Consensus $18.00 vs current $9.57
NASDAQ·Healthcare·Biotechnology
$9.57
+2.90%
Mkt Cap $1.68B
Buy
1
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
+88.1%
Consensus $18.00 vs current $9.57